Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women

A. E. Pontiroli, M. Alberetto, G. Pellicciotta, E. De Castro e Silva, A. De Pasqua, A. M. Girardi, G. Pozza

Research output: Contribution to journalArticlepeer-review

Abstract

Prolactin (Prl) release, both in the experimental animal and in man, is stimulated by serotonin (5HT) and inhibited by dopamine (DA). Data also suggest that LH release in the animal is stimulated by norepinephrine and inhibited by DA. The role of 5HT in the control of LH release is less clear. It would appear to stimulate episodic LH release and to inhibit the LH surge at the pro-oestrus in animals, but the effect of 5HT on LH release has not yet been evaluated in man. In the present paper we have studied the effect of various DA-ergic drugs (DA, iv l-dopa, po l-dopa and bromoergocriptine) and of two anti-5HT drugs, metergoline and methysergide, on Prl and LH release in normal women. DA-ergic drugs lowered plasma Prl and LH levels; anti-5HT drugs, at doses able to lower Prl levels, did not affect basal LH release nor the inhibiting effect of iv l-dopa on LH release. These data indicate that DA inhibits both LH and Prl release in normal women, and that 5HT stimulates Prl release but is not involved in the regulation of LH secretion. The fact that, at variance to all the DA-ergic drugs used, the two anti-5HT drugs did not vary LH release, suggests that metergoline and methysergide are devoid of DA-ergic activity in man, at least at the doses able to inhibit Prl release.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalActa Endocrinologica
Volume93
Issue number3
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women'. Together they form a unique fingerprint.

Cite this